Sabaa Pharmaceutical's profit plunge 99.73% in 2022: Egypt

Reuters Images

Saba International is an Egypt-based company operating in the pharmaceutical sector

Staff Writer, Arab Finance

March 28, 2023

PHOTO

The net profits after tax of Sabaa International for Pharmaceutical and Chemical Industry (SIPC) dropped by 99.73% year-on-year (YoY) to EGP 18,119 in 2022, compared to EGP 6.780 million, according to the firm’s financial results sent to the Egyptian bourse on March 27th.

The pharmaceutical company’s revenues declined to EGP 17.560 million last year from EGP 45.417 million in 2021.

Saba International is an Egypt-based company operating in the pharmaceutical sector, with a generic product portfolio that includes products focused on different therapeutic categories.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.